Skip to Main Content

Author Details

Jean K Lim
Icahn School of Medicine at Mount Sinai
1998
77
34
Kirsten Obernier (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
37142773Metagenomics-enabled reverse-genetics assembly and characterization of myotis bat morbillivirus.Nat Microbiol2023
37220746C5a-licensed phagocytes drive sterilizing immunity during systemic fungal infection.Cell2023
36377664Human Dectin-1 deficiency impairs macrophage-mediated defense against phaeohyphomycosis.J Clin Invest2022
33446526Aberrant type 1 immunity drives susceptibility to mucosal fungal infections.Science2021
33853355An Immuno-Cardiac Model for Macrophage-Mediated Inflammation in COVID-19 Hearts.Circ Res2021
33593976Quantifying Absolute Neutralization Titers against SARS-CoV-2 by a Standardized Virus Neutralization Assay Allows for Cross-Cohort Comparisons of COVID-19 Sera.mBio2021
33577760Leveraging the antiviral type I interferon system as a first line of defense against SARS-CoV-2 pathogenicity.Immunity2021
34529475Response to Comments on "Aberrant type 1 immunity drives susceptibility to mucosal fungal infections".Science2021
34644531Cardiomyocytes recruit monocytes upon SARS-CoV-2 infection by secreting CCL2.Stem Cell Reports2021
34611656Zoonotic potential of a novel bat morbillivirus.Res Sq2021
34523966The NF-κB Transcriptional Footprint Is Essential for SARS-CoV-2 Replication.J Virol2021
34403650Cardiomyocytes recruit monocytes upon SARS-CoV-2 infection by secreting CCL2.Stem Cell Reports2021
34220838Evaluating the Safety of West Nile Virus Immunity During Congenital Zika Virus Infection in Mice.Front Immunol2021
34081913SARS-CoV-2 infection induces beta cell transdifferentiation.Cell Metab2021
33446553GPER1 is required to protect fetal health from maternal inflammation.Science2021
32432714Protective Activity of Programmed Cell Death Protein 1 Blockade and Synergy With Caspofungin in a Murine Invasive Pulmonary Aspergillosis Model.J Infect Dis2020
33236003SARS-CoV-2 Infected Cardiomyocytes Recruit Monocytes by Secreting CCL2.Res Sq2020
32817961Quantifying absolute neutralization titers against SARS-CoV-2 by a standardized virus neutralization assay allows for cross-cohort comparisons of COVID-19 sera.medRxiv2020
32645325The Global Phosphorylation Landscape of SARS-CoV-2 Infection.Cell2020
32614902Zika virus tropism during early infection of the testicular interstitium and its role in viral pathogenesis in the testes.PLoS Pathog2020
32949997Dengue and Zika virus infections are enhanced by live attenuated dengue vaccine but not by recombinant DSV4 vaccine candidate in mouse models.EBioMedicine2020
32416070Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19.Cell2020
32305868Zika virus envelope nanoparticle antibodies protect mice without risk of disease enhancement.EBioMedicine2020
32268088Passenger Mutations Confound Phenotypes of SARM1-Deficient Mice.Cell Rep2020
30671055CCL7 Is a Negative Regulator of Cutaneous Inflammation Following <i>Leishmania major</i> Infection.Front Immunol2019
31072687Dengue and Zika: The Complexities of Being Related.Trends Immunol2019
31043537Human Monoclonal Antibodies Potently Neutralize Zika Virus and Select for Escape Mutations on the Lateral Ridge of the Envelope Protein.J Virol2019
30894466Atovaquone Inhibits Arbovirus Replication through the Depletion of Intracellular Nucleotides.J Virol2019
30737148Dengue Virus Immunity Increases Zika Virus-Induced Damage during Pregnancy.Immunity2019
30915442Sex differences in cytokine production following West Nile virus infection: Implications for symptom manifestation.Pathog Dis2019
31167928Lymphocyte-driven regional immunopathology in pneumonitis caused by impaired central immune tolerance.Sci Transl Med2019
29435494Tick-Borne Encephalitis Virus Vaccine-Induced Human Antibodies Mediate Negligible Enhancement of Zika Virus Infection <i>In</i><i>Vitro</i> and in a Mouse Model.mSphere2018
29803798Aspergillosis, eosinophilic esophagitis, and allergic rhinitis in signal transducer and activator of transcription 3 haploinsufficiency.J Allergy Clin Immunol2018
30282696Anti-α4β7 therapy targets lymphoid aggregates in the gastrointestinal tract of HIV-1-infected individuals.Sci Transl Med2018
30385750Human antibodies targeting Zika virus NS1 provide protection against disease in a mouse model.Nat Commun2018
30305360P2X Antagonists Inhibit HIV-1 Productive Infection and Inflammatory Cytokines Interleukin-10 (IL-10) and IL-1β in a Human Tonsil Explant Model.J Virol2018
29415879The homozygous CX3CR1-M280 mutation impairs human monocyte survival.JCI Insight2018
29018261Alveolar macrophages are critical for broadly-reactive antibody-mediated protection against influenza A virus in mice.Nat Commun2017
28360135Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity.Science2017
28278235A novel Zika virus mouse model reveals strain specific differences in virus pathogenesis and host inflammatory immune responses.PLoS Pathog2017
28356527Chemokine Receptor Ccr7 Restricts Fatal West Nile Virus Encephalitis.J Virol2017
28351919Contribution of the Purinergic Receptor P2X7 to Development of Lung Immunopathology during Influenza Virus Infection.mBio2017
29138302Disruption of the Opal Stop Codon Attenuates Chikungunya Virus-Induced Arthritis and Pathology.mBio2017
27001854Club cells surviving influenza A virus infection induce temporary nonspecific antiviral immunity.Proc Natl Acad Sci U S A2016
27777981Extrapulmonary <i>Aspergillus</i> infection in patients with CARD9 deficiency.JCI Insight2016
27142077Differences in Early Cytokine Production Are Associated With Development of a Greater Number of Symptoms Following West Nile Virus Infection.J Infect Dis2016
27191829Batf3-dependent CD103(+) dendritic cell accumulation is dispensable for mucosal and systemic antifungal host defense.Virulence2016
27183602Dual Function of Ccr5 during Langat Virus Encephalitis: Reduction in Neutrophil-Mediated Central Nervous System Inflammation and Increase in T Cell-Mediated Viral Clearance.J Immunol2016
26791948CXCR1-mediated neutrophil degranulation and fungal killing promote Candida clearance and host survival.Sci Transl Med2016
25547797CX3CR1 is dispensable for control of mucosal Candida albicans infections in mice and humans.Infect Immun2015
  • 1 - 50 of 77

Recommended Authors

Deepashri Rao
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 2018
Number of shared co-authors 1
Kathleen M Voss
Center for Innate Immunity and Immune Disease, University of Washington
Career Start Year 2016
Number of shared co-authors 3
Patrick Wong
Yale School of Medicine
Career Start Year 2016
Number of shared co-authors 0
Erik Van Dis
University of California berkeley
Career Start Year 2014
Number of shared co-authors 2
Ana Beatriz DePaula-Silva
University of Utah School of Medicine
Career Start Year 2014
Number of shared co-authors 1
Peiwen Lu
Yale University School of Medicine
Career Start Year 2013
Number of shared co-authors 0
Mary K McCarthy
University of Colorado School of Medicine
Career Start Year 2012
Number of shared co-authors 5
Craig B Wilen
Yale School of Medicine
Career Start Year 2010
Number of shared co-authors 4
Nicolas Tchitchek
Sorbonne University INSERM
Career Start Year 2010
Number of shared co-authors 2
Jessica B Graham
BIO5 Institute, The University of Arizona
Career Start Year 2009
Number of shared co-authors 3
Jacob D Eccles
University of Illinois at Chicago
Career Start Year 2008
Number of shared co-authors 0
Richard Green
Center for Innate Immunity and Immune Disease, University of Washington
Career Start Year 2005
Number of shared co-authors 6
Cherie T Ng
The Scripps Research Institute
Career Start Year 2004
Number of shared co-authors 1
Sunil Thomas
Lankenau Institute for Medical Research
Career Start Year 2004
Number of shared co-authors 4
Jennifer M Lund
Fred Hutchinson Cancer Research Center
Career Start Year 2003
Number of shared co-authors 11
Marion C Lanteri
Cerus Corporation
Career Start Year 2002
Number of shared co-authors 1
Thomas E Morrison
University of Colorado Anschutz Medical Campus
Career Start Year 2001
Number of shared co-authors 5
Satish K Pillai
Vitalant Research Institute, USA University of California san francisco
Career Start Year 2001
Number of shared co-authors 4
Sonja M Best
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 1998
Number of shared co-authors 13
Renee C Ireton
Center for Innate Immunity and Immune Disease, University of Washington
Career Start Year 1997
Number of shared co-authors 3
Larissa B Thackray
Washington University School of Medicine
Career Start Year 1996
Number of shared co-authors 5
Shelly J Robertson
National Institute of Allergy and Infectious Diseases
Career Start Year 1995
Number of shared co-authors 6
Daniel N Streblow
Vaccine and Gene Therapy Institute, Oregon Health and Science University
Career Start Year 1994
Number of shared co-authors 2
Mahdad Noursadeghi
University College London
Career Start Year 1992
Number of shared co-authors 14
Alec J Hirsch
Vaccine & Gene Therapy Institute, Oregon Health & Science University
Career Start Year 1992
Number of shared co-authors 2
P Robert Beatty
School of Public Health, University of California berkeley
Career Start Year 1990
Number of shared co-authors 1
Akiko Iwasaki
Yale University
Career Start Year 1990
Number of shared co-authors 3
Michael Gale
Center for Innate Immunity and Immune Disease, University of Washington
Career Start Year 1988
Number of shared co-authors 6
Ronald G Collman
University of Pennsylvania School of Medicine
Career Start Year 1988
Number of shared co-authors 2
Michael S Diamond
Washington University School of Medicine
Career Start Year 1982
Number of shared co-authors 14

Collaborators

Benjamin R tenOever
NYU Grossman School of Medicine
Co-authored papers 11
Susan L Stramer
Scientific Services
Co-authored papers 8
Benjamin E Nilsson-Payant
Hanover Medical School
Co-authored papers 7
Adolfo Garc??a-Sastre
Icahn School of Medicine at Mount Sinai
Co-authored papers 7
David Sachs
Icahn School of Medicine at Mount Sinai
Co-authored papers 6
Peter Palese
Icahn School of Medicine at Mount Sinai
Co-authored papers 5
Alain C Borczuk
Co-authored papers 5
Jenny Xiang
Caryl and Israel Englander Institute for Precision Medicine.
Co-authored papers 5
Tuo Zhang
Weill Cornell Medical College.
Co-authored papers 5
Stefania Pittaluga
National Cancer Institute, National Institutes of Health
Co-authored papers 5
Benhur Lee
Icahn School of Medicine at Mount Sinai
Co-authored papers 4
Viviana Simon
Icahn School of Medicine at Mount Sinai
Co-authored papers 3
Yasmine Belkaid
National Institute of Allergy and Infectious Diseases
Co-authored papers 3
Domenico Tortorella
Icahn School of Medicine at Mount Sinai
Co-authored papers 3
Alexandra F Freeman
National Institute of Allergy and Infectious Diseases
Co-authored papers 3
Douglas B Kuhns
Frederick National Laboratory for Cancer Research
Co-authored papers 3
Nicholas S Heaton
Duke University School of Medicine
Co-authored papers 3
Jennifer R Hamilton
University of California berkeley
Co-authored papers 2
Adam Jacobs
Co-authored papers 2
Shashank Tripathi
Indian Institute of Science
Co-authored papers 2
Melissa B Uccellini
Icahn School of Medicine at Mount Sinaigrid.59734.3c
Co-authored papers 2
Alan C Whitmore
University of North Carolina at Chapel Hill
Co-authored papers 2
Andrea V Gamarnik
Fundacion Instituto Leloir-CONICET
Co-authored papers 2
Kris M White
Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG)
Co-authored papers 2
Sergio A Lira
Co-authored papers 2
Mark T Heise
University of North Carolina at Chapel Hill.
Co-authored papers 2
Joshua D Milner
Columbia University
Co-authored papers 2
Benjamin K Chen
Co-authored papers 2
Nicolas Bouladoux
National Institute of Allergy and Infectious Diseases
Co-authored papers 2
Randy A Albrecht
Icahn School of Medicine at Mount Sinai
Co-authored papers 2
Release 1.2